Study identifier:D8850C00019
ClinicalTrials.gov identifier:NCT05687877
EudraCT identifier:N/A
CTIS identifier:N/A
General Drug Use-Result study of Evusheld Intramuscular Injection Set (Treatment and Prevention of Symptomatic Disease caused by SARS-CoV-2 Infection)
SARS-CoV-2 infection
N/A
No
-
All
700
Observational
n/a - n/a
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Sept 2024 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|